Tag: Multiple sclerosis

April 21, 2020

Scientists at Queen Mary University of London and the University of Roehampton, London, have discovered that patients suffering from obsessive compulsive disorder (OCD) have increased levels of a protein called Immuno-moodulin (Imood) in their lymphocytes, a type of immune cell. […]

April 20, 2020

Multiple sclerosis (MS) is known as “the disease with a thousand faces” because symptoms and progression can vary dramatically from patient to patient. But every MS patient has one thing in common: Cells of their body’s own immune system migrate […]

March 12, 2020

Virtual reality (VR) testing could help to detect the onset of balance problems in people with multiple sclerosis (MS), research from the University of North Carolina (UNC) has found. People with MS often have an increased risk of falling and […]

January 27, 2020

A new drug that could make it easier for doctors to diagnose multiple sclerosis (MS) in its earlier stages has been approved for its first human trials by the U.S. Food and Drug Administration (FDA). Created by Case Western Reserve […]

August 20, 2019

Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase. Many patients, however, develop progressive MS at a later stage, with disability becoming progressively worse. This type cannot be sufficiently treated at yet. […]

March 5, 2019

Multiple sclerosis (MS) is an autoimmune disorder that affects about 400,000 people in the United States and approximately 2.5 million people worldwide. MS affects the central nervous system. Symptoms often include muscle weakness, burning sensations, numbness, chronic pain, poor balance […]

January 10, 2019

There is currently no effective remedy for multiple sclerosis (MS). The sole therapeutic option is to alleviate its symptoms. As a result, this promising new approach to treating MS, developed by a team of scientists from the Cell Biology Unit […]

October 12, 2018

Teva Pharmaceutical Industries Ltd. today announced the European launch of Life Effects (https://lifeeffects.teva), a patient-centric website hosting content created by patients and checked by experts, at the European Committee for the Treatment and Research of Multiple Sclerosis (ECTRIMS) Congress in […]

September 4, 2018

Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system. The body’s own immune cells attack and damage the layer that surrounds nerve cells in the brain and spinal cord, which affects their ability to communicate with […]

May 30, 2018

Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have developed a 3D brain organoid that could have potential applications in drug discovery and disease modeling. This is the first engineered tissue equivalent to closely resemble normal human brain anatomy, containing […]

March 9, 2018

A surprise finding by medical scientists may lead to the development of a possible treatment for multiple sclerosis (MS). While examining human brain tissues, researchers from the University of Alberta and McGill University unexpectedly found that the tissues from people […]

November 28, 2017

Are parents responsible for adult children’s medical debts? Should people squeeze in appointments and expensive procedures before year’s end because of changes that might come with the GOP tax bill? Should consumers pay a broker to help them enroll in […]

October 17, 2017

Around 2.5 million people are affected by the autoimmune disease Multiple Sclerosis (MS), the commonest central nervous system disease among young adults. There are around 12,500 MS sufferers in Austria and 400 new cases every year. There is currently no […]

October 11, 2017

In a remarkably rapid translation of laboratory research findings into a treatment with the potential to benefit patients, UC San Francisco scientists have successfully completed a Phase II clinical trial showing that an FDA-approved antihistamine restores nervous system function in […]

September 20, 2017

Researchers uncover specific immune molecules that could act as biomarkers for more severe forms of multiple sclerosis. The findings might help to personalize treatments for those at most risk. Multiple sclerosis (MS) is a chronic condition affecting the central nervous […]

March 15, 2017

Queen’s University Belfast scientists have discovered that specific cells from the immune system are key players in brain repair — a fundamental breakthrough that could revolutionise the treatment of debilitating neurological disorders such as Multiple Sclerosis (MS). The research study, […]

February 2, 2016

A new way of using MRI scanners to look for evidence of multiple sclerosis in the brain has been successfully tested by researchers at The University of Nottingham and Nottingham University Hospitals NHS Trust. Multiple sclerosis (MS) is a neurological […]